<?xml version="1.0" encoding="UTF-8"?>
<ref id="B100-pharmaceuticals-14-00381">
 <label>100.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ohba</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Oka</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Ando</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Arahata</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Ikegaya</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Takagi</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Ogo</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Zhu</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Owada</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Kawamori</surname>
    <given-names>F.</given-names>
   </name>
  </person-group>
  <article-title>Antiviral effect of theaflavins against caliciviruses</article-title>
  <source>J. Antibiot.</source>
  <year>2017</year>
  <volume>70</volume>
  <fpage>443</fpage>
  <lpage>447</lpage>
  <pub-id pub-id-type="doi">10.1038/ja.2016.128</pub-id>
 </element-citation>
</ref>
